SBI Focused Equity mutual fund review: Promise of healthy track record
[ad_1]
BASIC FACTS
DATE OF LAUNCH
10 NOVEMBER 2004
CATEGORY
EQUITY
TYPE
FLEXI CAP
AUM*
Rs.26,218 Crore
BENCHMARK
S&P BSE 500 TOTAL
RETURN INDEX
WHAT IT COSTS
NAV**
GROWTH OPTION
Rs.229.83
IDCW
Rs.42.04
MINIMUM INVESTMENT
Rs.5,000
MINIMUM SIP AMOUNT
Rs.500
EXPENSE RATIO*** (%)
1.63
EXIT LOAD
1% for redemption
within 365 days.
*AS ON 31 JULY 2022
**AS ON 8 AUGUST 2022
***AS ON 30 JUNE 2022
FUND MANAGER
R. SRINIVASAN
TENURE: 13 YEARS, 2 MONTHS
Recent portfolio changes
New Entrants: Delhivery
Complete Exits: Tube Investments of India, .
Increasing allocation: Divi’s Laboratories, , , , , , , , .
Should you buy?
After repositioning, this fund retains its concentrated approach from its earlier avatar as
Emerging Businesses but takes a higher large-cap tilt now compared to its erstwhile mid- and small-cap flavour. It still retains sizeable presence in mid-caps compared to peers. The degree of portfolio concentration is also higher among peerset with a compact portfolio of around 21 stocks. It further sets itself apart with selective bets in foreign stocks. It leaves behind a healthy track record under previous mandate but with occasional bouts of sharp underperformance. Its performance since shifting mandate shows investors can expect continuity in the hands of its veteran fund manager.
(Source: Value Research)